Sanoculis
PrivateLast Round
Series C
Jul 28, 2022
Est. Valuation
$52M
Total Funding Raised
$26M
Company Overview
Sanoculis operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Series C round in July 2022.
Sanoculis is an ophthalmic medical device company that develops innovative, stent-free, and minimally invasive surgical solutions for the treatment of glaucoma.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sanoculis Comparables
Compare Sanoculis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iSTAR Medical | 82% | |
| Sight Sciences | 81% | |
| ViaLase | 80% |
For institutional investors. Book with your work email.
Sanoculis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 28, 2022 | ||||
| Series B | Sep 11, 2019 |
For institutional investors. Book with your work email.
Sanoculis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Infinity Group | Series C |
| Eckuity | Series C |
| T3 Technion Technology Transfer | VC Round |
| HCS Capital Partners | Series B |
Sanoculis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sanoculis's valuation, stock price, and market status.
Is Sanoculis a public or private company?
Sanoculis is a private company.
What is the current stock price of Sanoculis?
Sanoculis is a private company, so its shares have no public market price. Caplight tracks Sanoculis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sanoculis worth (valuation)?
Sanoculis's valuation is estimated at $52.0M based on funding round data.
Can I buy Sanoculis stock?
Sanoculis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sanoculis's last funding round?
Sanoculis's most recent funding round was Series C on July 28, 2022.
Who are the main investors in Sanoculis?
Key investors in Sanoculis include Infinity Group, Eckuity, T3 Technion Technology Transfer, HCS Capital Partners.
Will Sanoculis IPO soon?
No public IPO plans have been announced for Sanoculis.
How can I track Sanoculis secondary market activity?
Caplight tracks bids, offers, and trades in Sanoculis's shares on secondary markets.